Contract 75D30125D20400
Astrazeneca Pharmaceuticals Lp · Department Of Health And Human Services · March 25, 2025
Astrazeneca Pharmaceuticals Lp was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on March 25, 2025 for $11.52 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 24, 2025. If all options are exercised, the contract could reach $51.90 million.
Contract details
- PIID
- 75D30125D20400
- Award type
- Indefinite Delivery / Indefinite Quantity
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 25, 2025
- Latest action
- October 24, 2025
Description
2025-6 PEDIATRIC FLU VACCINES
Modification timeline
-
October 24, 2025Mod P00003 · Funding Only Action$11.52M
-
March 25, 2025Mod P00002$11.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30125D20400?
Contract 75D30125D20400 is a federal contract awarded to Astrazeneca Pharmaceuticals Lp by Department Of Health And Human Services on March 25, 2025 for $11.52 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75D30125D20400?
Astrazeneca Pharmaceuticals Lp won contract 75D30125D20400 from Department Of Health And Human Services.
How much is contract 75D30125D20400 worth?
Contract 75D30125D20400 has obligated $11.52 million to date, with a total potential value of $51.90 million if all options are exercised.